NCT01004172View on ClinicalTrials.gov

Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2017

Conditions
Metastatic Breast CancerBreast CancerProgressive Breast Cancer
Interventions
DRUG

carboplatin

DRUG

bevacizumab

DRUG

herceptin

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

02215

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER